EYPT
Price
$11.63
Change
+$0.08 (+0.69%)
Updated
Oct 17 closing price
Capitalization
939.16M
11 days until earnings call
WVE
Price
$7.81
Change
-$0.06 (-0.76%)
Updated
Oct 17 closing price
Capitalization
1.24B
19 days until earnings call
Interact to see
Advertisement

EYPT vs WVE

Header iconEYPT vs WVE Comparison
Open Charts EYPT vs WVEBanner chart's image
EyePoint Pharmaceuticals
Price$11.63
Change+$0.08 (+0.69%)
Volume$1.39M
Capitalization939.16M
Wave Life Sciences
Price$7.81
Change-$0.06 (-0.76%)
Volume$1.76M
Capitalization1.24B
EYPT vs WVE Comparison Chart in %
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. WVE commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and WVE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (EYPT: $11.63 vs. WVE: $7.81)
Brand notoriety: EYPT and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 128% vs. WVE: 81%
Market capitalization -- EYPT: $939.16M vs. WVE: $1.24B
EYPT [@Biotechnology] is valued at $939.16M. WVE’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileWVE’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • WVE’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 3 bullish TA indicator(s).

  • EYPT’s TA Score: 4 bullish, 4 bearish.
  • WVE’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than WVE.

Price Growth

EYPT (@Biotechnology) experienced а -14.30% price change this week, while WVE (@Biotechnology) price change was +2.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

WVE is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WVE($1.24B) has a higher market cap than EYPT($939M). EYPT YTD gains are higher at: 56.107 vs. WVE (-36.863). WVE has higher annual earnings (EBITDA): -134.84M vs. EYPT (-172.05M). EYPT has more cash in the bank: 256M vs. WVE (208M). WVE (21.7M) and EYPT (21.8M) have identical debt. WVE has higher revenues than EYPT: WVE (93.9M) vs EYPT (51.9M).
EYPTWVEEYPT / WVE
Capitalization939M1.24B75%
EBITDA-172.05M-134.84M128%
Gain YTD56.107-36.863-152%
P/E RatioN/AN/A-
Revenue51.9M93.9M55%
Total Cash256M208M123%
Total Debt21.8M21.7M100%
FUNDAMENTALS RATINGS
EYPT vs WVE: Fundamental Ratings
EYPT
WVE
OUTLOOK RATING
1..100
6519
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
48
Fair valued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9192
P/E GROWTH RATING
1..100
16100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (48) in the Biotechnology industry is in the same range as EYPT (68) in the Pharmaceuticals Major industry. This means that WVE’s stock grew similarly to EYPT’s over the last 12 months.

EYPT's Profit vs Risk Rating (80) in the Pharmaceuticals Major industry is in the same range as WVE (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to WVE’s over the last 12 months.

EYPT's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as WVE (100) in the Biotechnology industry. This means that EYPT’s stock grew similarly to WVE’s over the last 12 months.

EYPT's Price Growth Rating (91) in the Pharmaceuticals Major industry is in the same range as WVE (92) in the Biotechnology industry. This means that EYPT’s stock grew similarly to WVE’s over the last 12 months.

EYPT's P/E Growth Rating (16) in the Pharmaceuticals Major industry is significantly better than the same rating for WVE (100) in the Biotechnology industry. This means that EYPT’s stock grew significantly faster than WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EYPTWVE
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WVE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAVQX16.340.08
+0.49%
Lord Abbett Fundamental Equity R2
JAREX13.810.04
+0.29%
Easterly Global Real Estate A
RAAIX10.51N/A
N/A
Altegris/AACA Opportunistic Real Estt I
FEQMX48.37N/A
N/A
Fidelity Advisor Emerging Markets M
LISGX72.23-0.18
-0.25%
ClearBridge Small Cap IS

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with OCUL. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.69%
OCUL - EYPT
62%
Loosely correlated
-2.95%
LYRA - EYPT
58%
Loosely correlated
-3.47%
ATHE - EYPT
54%
Loosely correlated
+1.24%
BEAM - EYPT
51%
Loosely correlated
+0.74%
DNLI - EYPT
48%
Loosely correlated
-0.36%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been closely correlated with PRQR. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if WVE jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
-0.76%
PRQR - WVE
67%
Closely correlated
-0.71%
KRRO - WVE
56%
Loosely correlated
-13.27%
OCUL - WVE
50%
Loosely correlated
-2.95%
XENE - WVE
46%
Loosely correlated
-1.28%
EYPT - WVE
45%
Loosely correlated
+0.69%
More